Delayed and persistent multisystem toxicities of adjuvant anti-PD-1 therapy for stage III melanoma

Eur J Cancer. 2023 Oct:192:113255. doi: 10.1016/j.ejca.2023.113255. Epub 2023 Aug 16.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Melanoma* / drug therapy
  • Melanoma, Cutaneous Malignant
  • Skin Neoplasms* / drug therapy